In addition, after HSPC transplantation, the peripheral blood CD4+ T cells recovered to their normal range by month 6, and the acute lymphoblastic leukemia was in complete remission for 19 months, even though CCR5 editing efficiency in bone marrow cells was less than 8.28% (151). The gene discussed is CCR5; the disease is acute lymphoblastic leukemia.